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Abstract: 
 
Cancer treatment is associated with adverse changes in strength, body composition, physical 
function, and quality of life. Exercise training reduces cancer incidence and mortality rates and 
may offset some of the treatment-related effects. To determine the independent effects of 
strength training (ST) on the effects of cancer treatment, an initial search was performed in 
March and then updated in November 2015. Additional articles were identified by scanning 
references from relevant articles. Studies using traditional ST on strength, body composition, 
aerobic capacity, functional assessments, and psychosocial parameters were included. Excluded 
studies had no objective strength measurement or combined ST with additional exercise. Mean 
and standard deviations from 39 studies across seven cancer types were extracted for main 
outcomes. ST-induced change scores with 95 % confidence intervals were calculated and were 
evaluated with paired t tests, where appropriate. Twenty to fifty percent improvements in 
maximal strength were observed, indicating that the ST programs were effective. Physical 
function was also enhanced (7–38 %), although gains were less consistent. Body composition 
and psychosocial changes were rare, with only a few changes in selected cancer types. As 
such, ST appears to promote benefits that may be specific to cancer types. Strength was the only 
consistent outcome that improved in all cancer survivors. However, these gains in strength are 
still of tremendous importance, given its impact on functionality and quality of life. Several 
practical considerations for exercise testing, training, and data reporting are presented for 
consideration to improve the overall depth of the field. 
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Article: 
 
Introduction 
 
Cancer incidence rates in the USA rose steadily until the mid-1990s before plateauing, and 
available data from the most recent 5 years are showing signs of decline for certain cancers [1]. 
However, recent estimates suggest there are nearly 14.5 million cancer survivors and this number 
is expected to grow by another 4 million over the next 10 years [2] with treatment-related costs 
that exceed 75 billion dollars annually [3]. In 2015 alone, 1.7 million new cases were anticipated 
to be diagnosed with ~600,000 cancer-related deaths, although mortality rates have started to 
improve [1]. The decrease in mortality may be the result of early detection and treatment, 
improved treatment protocols, and lower smoking rates. 
 
Cancer treatments may include surgery, radiation, chemotherapy, immunotherapy, and hormone 
therapies that effectively reduce tumor burden, as 5-year survival rates have increased regularly 
since the 1970s [1]. However, simply living longer poses many challenges for survivors, as 
numerous side effects persist during and after treatment with the most common ones including 
debilitating fatigue and reduced quality of life (QoL) [4, 5]. Additionally, treatment-related 
effects that alter muscle strength and body composition (either directly or indirectly via physical 
inactivity) promote loss of physical function, which further exacerbates fatigue and QoL [4]. 
Interestingly, many of these side effects are similar to those observed during natural aging 
processes but appear to be accelerated in cancer populations [6, 7, 8], possibly due to the harsh 
nature of anti-cancer treatments [9]. As such, therapies that assist in the mitigation of common 
age-related declines in physical, mental, and functional capacities are excellent candidates for 
alleviating or even reversing the side effects of cancer treatment. 
 
Exercise, and strength training (ST) in particular, has long been used to reduce the effects of 
aging and chronic disease [10] and is now becoming a focal point in cancer patients, before, 
during, and after treatment. Epidemiological studies have shown that physical activity levels are 
associated with decreased incidence rates among certain cancer types [11, 12, 13], possibly via 
alterations in body composition, hormones, inflammatory markers, and immune function [14]. 
Following diagnosis, physical activity levels appear critical in reducing the risk of cancer-related 
mortality [15, 16], with cancer survivors engaging in higher levels of physical activity showing 
improved mortality outcomes. Both scenarios create a strong overall case for exercise 
interventions in cancer survivors and also those at high risk for cancer. Aerobic training was the 
first intervention used in breast cancer survivors to help offset weight gain associated with 
treatment [17]. From this initial study, the field of exercise oncology was established and it grew 
slowly over the first decade [18]. More recently, studies have expanded to also include ST or 
combined training across many different types of cancer [18, 19, 20] with generally beneficial 
effects being reported along with minimal adverse events. While exercise interventions have 
gained traction as a potential complementary therapy and both types of exercise have benefits to 
cancer survivors, there are certain traits that change only with ST, specifically, muscle 
hypertrophy and strength. ST-induced musculoskeletal gains may improve physical function, 
decrease fatigue, and ultimately produce a higher QoL. Because aerobic and ST have the 
potential to interfere with the respective adaptation processes [21], examining ST in isolation in 
cancer patients is important in determining the effectiveness of this specific modality in reducing 
treatment-related side effects. In primarily the past 10 years, studies have begun to explore the 
effects of ST alone in hormone-dependent cancers 
[22, 23, 24, 25••, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39••, 40, 41, 42, 43, 44, 45, 46
••, 47••, 48], colorectal [49] and lung [50, 51], which are among the most common cancer types 
and leading cause of cancer-related mortality [1, 2]. 
 
The main objective of this systematic review was to examine the independent effects of 
resistance training programs on reducing or reversing the adverse effects of cancer treatment. 
Specifically, studies were included only if objective measures of strength were used as a means 
of assessing the efficacy of the training program as improvements in strength have been shown 
to be associated with improvements in physical function and QoL in both healthy and cancer 
populations [35, 52]. This approach expands on previous articles in this area [6, 19, 53••] by 
utilizing objective strength measures, the inclusion of less common cancers, and incorporates 
recently published studies. Results are presented by cancer type and in descending order of 
number of studies rather than by specific outcomes, as the latter varied widely within and also 
across different types of cancer. 
 
Methodology 
 
A systematic review of the literature was conducted using the search engine PubMed to identify 
ST publications in cancer populations. The initial search was run on March 6, 2015 with a final 
update on November 10, 2015 to include any recent publications that had not been captured 
initially. The search terms utilized were all possible combinations of the terms in list 1 (“strength 
training,” “resistance training,” “weight training,” and “functional overload”) and list 2 
(“oncology,” “cancer,” or “neoplasm”) separated by the “AND” operator (i.e., strength training 
AND oncology). The search did not discriminate based on cancer type and had no date 
restrictions. Reference lists of relevant publications were also utilized. 
 
Study Selection 
 
The publications included in this review were restricted to studies that evaluated the effects of 
ST only or studies that included an arm of ST only. The included studies objectively measured 
the independent effects of traditional resistance training (body weight, dumbbells, bars, and 
bands) on the following patient-related outcomes: isokinetic strength, isometric strength, 
maximal strength (1RM), multiple RM, grip strength, body composition, aerobic capacity, 
functional assessments, psychosocial parameters, and blood biomarkers. Studies that were 
ultimately excluded from the review included those that (1) had no objective measure of 
strength, (2) had no ST intervention, (3) combined ST with any other mode of exercise, (4) 
included pediatric patients or non-cancer participants, (5) were not published in English, and (6) 
there was no data reported. The first screening eliminated publications based on the title of the 
publication. The second screening eliminated studies based on a reading of abstract. The third 
and final screening eliminated studies based on a reading of the full text. In the case of missing 
data or unclear methodology, efforts were made to contact the corresponding author prior to 
elimination. Two reviewers (CW and TA) evaluated each study, and a consensus on inclusion 
was reached. In instances where consensus was not reached, a third reviewer (EH) made the final 
decision. Figure 1 below presents the literature review citation selection flowchart. 
 
Data Extraction 
 
In studies that met all inclusion criteria, baseline and post-ST means and standard deviations 
were extracted for all main outcome variables. Values were converted to SI units, as required, 
and averaged for statistical analysis based on cancer type. As a wide range of strength tests were 
performed, upper and lower body composite strength scores were derived by combining and 
averaging strength values for each study within their respective cancer type. Change scores with 
ST were calculated and averaged by subtracting the baseline value from the post-training score. 
 
 
Fig. 1 Flowchart for inclusion or exclusion of literature within this review 
 
Statistical Analysis 
 
Descriptive statistics (mean and standard deviations) were calculated on all fitness parameters, 
except for those parameters that were derived from a single study. For those parameters where 
two or more studies used the same testing procedure, paired-sample t tests were used to compare 
baseline and post-exercise training data, while 95 % confidence intervals were computed for the 
calculated change scores. An alpha level of 0.05 was set a priori for all procedures. For those 
parameters where only one study used a particular testing procedure, means, standard deviations, 
and any statistical differences from baseline were reported based on information provided in the 
original publication and no further analyses were performed. 
 
Results 
 
The cancer survivors in the current review were mostly middle-aged and older adults, with the 
exception of germ cell patients where survivors were much younger. The interventions tended to 
be of moderate length (12–16 weeks), although two trials were as short as 8–9 weeks and the 
longest was 2 years. The intensities of the ST programs were highly variable but were primarily 
moderate to high intensity (as defined in healthy older adults [54]) and were typically performed 
two to three times per week in early/localized cancer stages, although exceptions did exist 
(Table 1). 
 
Table 1. Summary of study participant characteristics and training interventions 
Cancer type Study 
no. 
Age 
(year) 
Intervention length 
(week) 
Training frequency 
(day/week) 
Intensity 
(%1RM) 
Disease stage 
Breast 16 57 (49–
68) 
31.5 (8–104) 2 (2–4) 50–85 % Majority early, mixed [24, 27] 
Prostate 11 67 (65–
73) 
16 (10–24) 3 (2–3) Variable Majority early, mixed [37], 
advanced [23] 
Mixed 4 59 (47–
70) 
24 (12–52) 3 (2–4) Variable Early [57], advanced [39••], 
unknown [58, 59] 
Head and 
neck 
4 54 (52–
55) 
12 (−) 2 (2–3) 60–70 %, 
variable 
Majority mixed, early [70] 
Lung 2 65 (63–
67) 
8 (6–10) 2.5 (2–3) 60–85 % Early 
Gastro-
intestinal 
1 59 (−) 12 (−) 2 (−) 60–80 % Advanced 
Germ cell 1 34 (−) 9 (−) 3 (−) 10–15RM Mixed 
Data are reported as mean (range) 
 
Breast Cancer. Sixteen studies met the study inclusion criteria. 
 
Strength Assessment: Overall, ST led to large increases in lower (29 %, P < 0.001) and 
upper (23 %, P < 0.001) body composite strength scores and 10RM chest press 
(88 %, P = 0.017; Table 2). In the controls, strength significantly improved in lower body 
(5.2 %, P = 0.001) but showed only a trend for upper body composite scores 
(10 %, P = 0.051); however, the magnitude of the change was much smaller when 
compared to survivors in the ST groups. This suggests a slight learning effect instead of 
improvement derived from main physiological adaptations expected with regular strength 
training. Chest press and leg extension 8RM were reported to increase with ST [24], 
while grip strength was increased in both groups. 
 
Body Composition: Absolute body composition was unaltered for fat and lean mass but 
ST decreased percent body fat (P = 0.006) in the exercise group, while the controls had a 
significant increase (P = 0.004). Bone mineral density did not change in either group nor 
did ST alter bone formation and reabsorption biomarkers [29]. 
 
Table 2. Effects of ST on strength, body composition, physical function, aerobic capacity, and 
psychosocial parameters in breast cancer survivors 
  Study no. Subject no. Baseline mean (SD) Post-ST mean (SD) Mean change 95 % CI Pvalue 
Strength 
 Lower body composite (kg) 
 Exercise 15 756 79.2 (12.6) 102.0 (19.2) 22.9 72.2–86.1 <0.001 
 Control 10 568 96.6 (38.7) 101.6 (40.4) 5.1 68.9–124.3 0.001 
8RM leg extension (kg) 
 Exercise 1a 82 24.4 (11.2) 32.8 (12.6)b 8.2 – – 
 Control 1a 82 22.8 (8.9) 24.6 (7.8)b 1.4 – – 
Upper body composite (kg) 
 Exercise 17 809 26.1 (12.9) 32.2 (15.7) 6.08 19.5–32.7 <0.001 
 Control 11 540 22.3 (8.4) 24.6 (8.4) 2.31 16.7–27.9 0.051 
8RM chest press (kg) 
 Exercise 1a 82 23.2 (7.2) 31.9 (10.8)b 8.8 – – 
 Control 1a 82 22.8 (8.9) 24.6 (7.8)b 1.5 – – 
10RM chest press (kg) 
 Exercise 2 20 13.9 (2.6) 26.1 (3) 12.2 −9.3–37 0.017 
 Control – – – – – – – 
Grip strength (kg) 
 Exercise 3 195 28.9 (6.6) 30.9 (6.0) 1.9 12.7–45.2 0.040 
 Control 2 165 25.8 (0.2) 27.0 (0.4) 1.2 23.8–27.7 0.053 
Body composition 
Absolute FM (kg) 
 Exercise 5 340 30.2 (2.5) 30.03 (1.9) −0.2 27–33.4 0.640 
 Control 3 317 30.1 (1.63) 30.1 (1.67) 0.02 26.06–34.1 0.970 
Absolute LM (kg) 
 Exercise 4 192 43.3 (5.1) 43.5 (4.3) 0.2 35.2–51.4 0.710 
 Control 2 89 46.7 (3.4) 46.5 (2.8) −0.3 16.2–77.2 0.677 
BF (%) 
 Exercise 7 471 38.7 (3.1) 38.3 (3.1) −0.4 35.8–41.5 0.006 
 Control 4 363 39.2 (0.5) 39.5 (0.6) 0.3 38.3–40 0.004 
BMD (g/cm3) 
 Exercise 3 60 1.0 (0.1) 1.0 (0.1) 0.0 0.7–1.4 0.266 
 Control 2 42 0.9 (0.1) 0.9 (0.1) 0.0 −0.3–2.2 0.446 
Functional assessments 
12-min walk (m) 
 Exercise 1a 21 1020 (357) 1055 (177)b 35 – – 
 Control 1a 23 1035 (257) 944 (241) −91 – – 
DASH 
 Exercise 1a 26 11.4 (9.1) 10.2 (11) −1.2 – – 
Tandem balance (s) 
 Exercise 1a 110 14.2 8.6b −5.6 – – 
 Control 1a 113 14.6 11.5b −3.1 – – 
Arm curl (reps in 30 s) 
 Exercise 2 20 17.4 (0.3) 20.5 (0.1) 3.1 14.9–19.9 0.021 
Chair stand (reps in 30 s) 
  Study no. Subject no. Baseline mean (SD) Post-ST mean (SD) Mean change 95 % CI Pvalue 
 Exercise 2 20 14.3 (2.5) 17.0 (3.5) 2.7 −8.6–37.2 0.161 
Aerobic capacity 
VO2Peak (mL/kg/min) 
 Exercise 2 91 24.5 (1.5) 24.2 (0.0) −0.3 11.8–37.2 0.442 
 Control 1a 82 24.8 (6.2) 23.5 (5.4) −1.6 – – 
Psychosocial 
Anxiety 
SSAS 
 Exercise 1a 82 42.0 (12) 36.4 (12.7)c −5.7 – – 
 Control 1a 82 42.0 (13.7) 37.4 (12)c −4.2 – – 
Depression 
ESDS 
 Exercise 1a 82 13.8 (10.1) 10.6 (9.5)c −2.3 – – 
 Control 1a 82 13.9 (9.7) 10.8 (9.4)c −1.9 – – 
Fatigue 
FACT-A 
 Exercise 1a 82 34.3 (10.1) 36.3 (9.4)c 0.9 – – 
 Control 1a 82 34.6 (11.1) 34.9 (12.5)c −0.7 – – 
QOL 
FACT-A 
 Exercise 1a 82 132.2 (23.5) 140.9 (24.8)c 5.9 – – 
 Control 1a 82 135.3 (28.1) 139.9 (28.2)c 1.0 – – 
Body image and relationships scale 
 Exercise 4 264 76.3 (9.4) 64.3 (9.6) −11.9 61.2–91.3 0.051 
 Control 1a 121 76.8 (17.3) 74.7 (18.2) – – – 
SF36 
 Exercise 1a 112 52.1 (9.4) 53.2 (9.6)c 1.7 – – 
 Control 1a 120 53.9 (7.5) 53.8 (8.7)c 2.2 – – 
Data from references [22, 24, 25••, 26, 27, 28, 29, 30, 38, 40, 41, 42, 43, 44, 48, 71]. Lower body 
composite includes leg extension and leg press. Upper body composite includes chest and 
overhead presses and seated row 
RM repetition maximum; FM fat mass; LM lean mass; BF body fat; BMD bone mineral 
density; DASH disabilities of the arm, shoulder, and hand; SSAS Spielberger state anxiety 
scale; ESDS epidemiologic studies depression scale; FACT-A functional assessment of cancer 
therapy–anemia; BIRS body image and relationships scale 
aAs reported in original research article for variables with only one study 
bSignificantly different from baseline value, per original article 
cNo within-group P value provided in original article or supplementary data 
 
Functional Assessment: Arm curls completed in 30 s were improved with ST 
(18 %, P = 0.021), but chair stands were not. Single studies reported that ST improved 
12-min walk distance [28] and tandem balance [30] but not shoulder function [38]. 
Aerobic capacity did not change with ST or in controls [24]. 
 
Psychosocial Assessment: Body image and relationship scores decreased by 19 %, 
indicating less concern with physical appearances following ST. In the other limited data 
available from single studies, ST reduced anxiety and depression and improved fatigue 
and QoL [24]. However, controls had similar responses with slightly smaller magnitudes 
except fatigue, which increased. However, no within-group comparisons were reported in 
this study. 
 
Table 3. Effects of ST on strength, body composition, physical function, aerobic capacity, and 
psychosocial parameters in prostate cancer survivors 
  Study no. Subject no. Baseline mean (SD) Post-ST mean (SD) Mean change 95 % CI Pvalue 
Strength 
Lower body composite (kg) 
 Exercise 12 649 110.6 (56.8) 142.8 (70.8) 32.2 18.8–45.7 <0.001 
 Control 4 154 98.8 (56.4) 98.2 (57.6) −0.6 −3.8–2.6 0.591 
Upper body composite (kg) 
 Exercise 13 1032 42.7 (11.2) 53.5 (13.4) 10.8 8.44–13.21 <0.001 
 Control 4 166 39.6 (14.6) 38.7 (14.0) −1.0 −132.5–130.5 0.348 
8RM leg extension (kg) 
 Exercise 4 459 98.7 (13.4) 124.0 (17.1) 25.4 19.0–31.8 <0.001 
 Control 1a 41 117.3 (53.5) 119.2 (55.9)c 1.9 – – 
8RM chest press (kg) 
 Exercise 4 459 44.6 (10.7) 54.5 (13.4) 9.8 −5.8–25.5 0.005 
 Control 1a 41 55.2 (13.3) 52.9 (14.6)b −2.3 – – 
Body composition 
Absolute FM (kg) 
 Exercise 4 65 27.8 (2.4) 27.6 (2.7) −0.2 −0.9–0.4 0.337 
 Control 2 40 26.8 (0.6) 27.1 (0.6) 0.3 – 0.500 
Absolute LM (kg) 
 Exercise 4 95 62.0 (3.6) 62.6 (3.7) 0.6 −0.5–1.8 0.123 
 Control 2 40 55.6 (3.3) 55.2 (3.82) −0.4 −4.8–4.1 0.500 
BF (%) 
 Exercise 7 145 31.0 (1.1) 30.8 (1.3) −0.2 −0.6–0.08 0.116 
 Control 3 81 31.5 (1.4) 32.2 (1.7) 0.7 −1.2–2.6 0.261 
BMC (kg) 
 Exercise 2 27 3.1 (0.0) 3.0 (0.0) −0.1 −0.4–0.36 0.626 
Functional assessments 
Up and go (s) 
 Exercise 6 63 6.1 (1.0) 5.6 (0.9) −0.6 −0.8–−0.4 0.001 
Stair climb (s) 
 Exercise 3 52 5.9 (1.1) 5.4 (1.0) −0.5 −1.0–0.05 0.060 
 Control 1a 30 5.9 (1.0) 5.9 (1.0) 0.0 −0.2–0.1 – 
Chair stands (s) 
 Exercise 2 27 14.9 (0.6) 13.8 (4.7) −1.2 −48.8–46.5 0.811 
Chair stand (reps) 
 Exercise 4 431 13.3 (2.5) 15.1 (2.5) 1.8 9.4–17.3 0.006 
 Control 1a 30 16.0 (3.0) 16.0 (3.0) 0 – – 
6-min walk (m) 
 Exercise 4 36 525.6 (58.8) 565.7 (54.8) 40.1 19.3–60.9 0.009 
6-m walk (s) 
  Study no. Subject no. Baseline mean (SD) Post-ST mean (SD) Mean change 95 % CI Pvalue 
 Exercise 4 54 4.8 (0.8) 4.3 (0.8) −0.5 −0.8–−0.2 0.019 
 Control 1a 10 4.5 (0.6) 4.8 (0.4)c 0.3 – – 
400-m walk (s) 
 Exercise 4 415 284.9 (23.7) 262.5 (15.6) −22.5 −42.7–−2.21 0.039 
 Control 1a 10 280.8 (53.0) 286.5 (50.5) 5.7 – – 
Aerobic capacity 
VO2 peak (mL/kg/min) 
 Exercise 3 80 28.5 (2.8) 28.9 (3.7) 0.5 −1.9–2.9 0.464 
 Control 1a 41 28.8 (5.1) 27.6 (5.1)b −1.2 – – 
Psychosocial 
Anxiety 
BSI-18 (1–5) 
 Exercise 1a 10 1.7 (1.8) 3.3 (5.5)b 1.6 – – 
 Control 1a 10 1.5 (2.0) 2.7 (3.2)c 1.2 – – 
Depression 
BSI-18 (1–5) 
 Exercise 1a 10 2.9 (4.0) 3.7 (5.7) 0.8 – – 
 Control 1a 10 1.4 (2.1) 3.7 (6.1) 2.3 – – 
Fatigue 
FACT-F subscale 
 Exercise 3 66 41.7 (2.0) 43.9 (1.6) 2.2 0.8–3.6 0.020 
 Control 1a 41 44.6 (8.7) 42.1 (8.8)b −2.5 – – 
MFSI (short form) 
 Exercise 1a 10 5.2 (16.8) 8.8 (24.9)c 3.6 – – 
 Control 1a 10 6.0 (12.3) 3.8 (13.7)c −2.2 – – 
BFI 
 Exercise 1a 17 28.0 (21.4) 17.5 (18.1) −10.5 – – 
QOL 
FACT-G (0–104) 
 Exercise 1a 40 88.2 (13.0) 92.4 (13.2)b 4.2 – – 
 Control 1a 41 90.0 (13.0) 89.8 (13.1)c −0.2 – – 
FACT-P 
 Exercise 2 98 115.7 (3.5) 120.5 (0.4) 4.8 −30.2–39.7 0.334 
 Control 1a 73 120.9 (13.6) 117.6 (14.9)c −3.3 – – 
Data from references [23, 31, 32, 33, 34, 35, 36, 37, 45, 46••, 47••]. Lower body composite 
includes leg extension and leg press. Upper body composite includes chest and overhead presses 
and seated row 
RM repetition maximum; FM fat mass; LM lean mass; BF body fat; BMD bone mineral 
density; DASH disabilities of the arm, shoulder, and hand; SSAS Spielberger state anxiety 
scale; ESDS epidemiologic studies depression scale; FACT-A functional assessment of cancer 
therapy–anemia, BIRS body image and relationships scale 
aAs reported in original research article for variables with only one study 
bSignificantly different from baseline value, per original article 
cNo within-group P value provided in original article or supplementary data 
 
 
Prostate Cancer. Eleven studies met the study inclusion criteria. 
 
Strength Assessment: Similar to breast cancer, lower (29 %, P = 0.006), upper 
(25 %, P < 0.001), and 8RM leg extension (26 %, P < 0.001) and 8RM chest press 
(22 %, P = 0.005; Table 3) increased significantly with ST. Changes in the controls were 
minimal, with no change for upper or lower body strength or leg extension 8RM [37] and 
a decrease in chest press 8RM [37]. 
 
Body Composition: Body composition measures were unaltered, as ST did not 
significantly decrease fat mass or increase bone mineral content. There was a weak trend 
for increased lean mass and reduced % fat, but neither was significant (both P = 0.12). 
Similarly, a lack of change was present in controls, although the small differences in the 
opposite direction from ST were observed. Regional body composition showed more 
change, with thigh muscle volume (cm3) being significantly increased by 6.4 % [35] and 
quadriceps area (cm2) in the right (pre 73.7 (3.5), post 75.1 (3.3); 95 % CI 72.3–
75.1; P = 0.045) but not left (pre 72.1 (3.6), post 73.5 (4.7); 95 % CI 70.7–
73.5; P = 0.330) leg increased following ST. ST increased muscle fiber cross-sectional 
area by 12 %, and controls decreased by −8.5 % with the most pronounced changes 
occurring in type II fibers [46••]. 
 
Functional Assessment: Timed up and go (−8.2 %, P = 0.001); chair stand repetitions 
(14 %, P = 0.006); and 6-m (−10 %, P = 0.019), 400-m (−7.9 %, P = 0.039), and 6-min 
(7.6, P = 0.009) walk times all improved significantly with ST, along with a trend for 
improved stair climb time (−8.5 %, P = 0.060). There was no change in maximal oxygen 
uptake. Control data for functional assessments was limited to single studies for each 
task, but 6- and 400-m walk times were 6.7 and 2.0 % slower, respectively, with reduced 
maximal oxygen uptake [37]. Chair stand repetitions and stair climb time did not change. 
 
Psychosocial Assessment: Like with breast cancer, ST studies in prostate cancer used 
many different tools to assess fatigue and QoL, making comparisons difficult. Only one 
questionnaire was used repeatedly and ST increased FACT-F score by 5.3 % (P = 0.020). 
In other questionnaires, regardless of which particular one was used, ST appears to 
improve fatigue scores (indicating less fatigue), whereas controls tended to worsen. QoL 
was unchanged with ST when a questionnaire with prostate specific questions (FACT-P) 
was used but improved in a single study using the more general questionnaire (FACT-G) 
[37]. The QoL change scores with ST in FACT-P and FACT-G were very similar, 
suggesting that improvements with exercise may be influencing. 
 
Biomarker Assessment: Biomarkers remained stable, as changes in prostate specific 
antigen (ST −1.3, P = 0.184; Con 2.7 ng/ml, P = 0.504) and testosterone (ST 
0.1, P = 0.854; Con −0.9 pmol/l, P = 0.604) were absent from both groups. Hemoglobin 
(g/l) had a non-significant decrease of 1.8 % with ST (pre 143.2 (2.7), post 140.6 (0.9); 
95 % CI 119.1–167.3; P = 0.488) and controls from a single study decreased by −3.6 % 
[37]. Growth hormone and cortisol levels where unchanged with ST [55]. 
 
Table 4. Effects of ST on strength, body composition, physical function, and psychosocial 
parameters in head and neck cancer survivors 
  Study no. Subject no. Baseline mean (SD) Post-ST mean (SD) Mean Change 95 % CI Pvalue 
Strength 
Dead lift (kg) 
 Exercise 1a 5 107.9 (37.8) 115.0 (54.4)c 7.1 – – 
 Control 1a 8 94.2 (46.4) 92.1 (41.3)c −2.1 – – 
Upper body composite (kg) 
 Exercise 4 108 28.8 (13.1) 40.8 (17.8) 12.0 4.4–19.6 0.015 
 Control 4 100 24.4 (9.8) 29.1 (11.8) 4.7 1.3–8.2 0.022 
Grip strength (kg) 
 Exercise 2 18 61.5 (30.0) 62.7 (33.1) 1.2 −26.8–29.2 0.682 
 Control 1a 8 39.1 (14.1) 35.5 (11.6) −3.6 – – 
Body composition 
Absolute FM (kg) 
 Exercise 1a 19 17.1 (9.2) 16.9 (9.3)c −0.2 – – 
Absolute LM (kg) 
 Exercise 2 26 111.6 (5.2) 106.1 (2.0) −5.5 −67.8–62.4 0.688 
 Control 1a 8 62.8 (17.8) 60.1 (3.3) −2.7 – – 
Functional assessments 
Chair rise (s) 
 Exercise 1a 5 4.4 (4.1) 2.9 (0.7) −1.5 – – 
 Control 1a 8 3.1 (0.8) 3.1 (0.4) 0.0 – – 
Stair climb (steps/s) 
 Exercise 1a 19 2.6 (0.5) 3.0 (0.4) 0.4 – – 
6-min walk test (m) 
 Exercise 1a 11 544.0 (112.7) 593.5 (71.6) 49.5 – – 
10-m fast walk (m/s) 
 Exercise 1a 19 2.1 (0.3) 2.3 (0.4) 0.2 – – 
Arm curl (reps in 30 s) 
 Exercise 1a 19 19 (4) 24 (5) 5 – – 
Chair stand (reps in 30 s) 
 Exercise 2 30 19.1 (0.1) 23.8 (1.1) 4.7 −4.2–13.6 0.094 
Psychosocial 
Fatigue 
FACT-anemia 
 Exercise 1a 27 33.5 (9.7) 36.7 (9.0)c 3.2 – – 
 Control 1a 25 32.7 (11) 34.3 (11.1)c 1.6 – – 
FACT-F 
 Exercise 1a 7 14.4 (6.7) 19.0 (10.0)c 4.6 – – 
 Control 1a 8 10.1 (7.4) 16.5 (11.1)c 6.4 – – 
EORTC QLQ-C30 (0–100) 
 Exercise 1a 19 50 (20) 24 (14)b −26 – – 
QOL 
FACT-anemia 
 Exercise 1a 27 133.9 (23.8) 142.4 (27.0)c 8.5 – – 
 Control 1a 25 130.6 (30.9) 134.4 (34.0)c 3.8 – – 
  Study no. Subject no. Baseline mean (SD) Post-ST mean (SD) Mean Change 95 % CI Pvalue 
FACT-General 
 Exercise 1a 7 73.8 (14.8) 70.6 (18.2)c −3.2 – – 
 Control 1a 8 90.4 (10.8) 84.6 (13.8)c −5.8 – – 
Data from references [56, 61, 70, 72]. Upper body composite includes chest press and seated row 
FACT-anemia functional assessment of cancer therapy–anemia, FACT-F functional assessment 
of cancer therapy–fatigue, EORTC QLQ-C30 European Organization for Research and 
Treatment of Cancer Quality of Life Questionnaire 
aAs reported in original research article for variables with only one study 
bSignificantly different from baseline value, per original article 
cNo within-group P value provided in original article or supplementary data 
 
Head and Neck Cancer. Four studies met the study inclusion criteria. 
 
Strength Assessment: Upper body strength was improved (42 %, P = 0.015) with ST and 
also improved in controls (19 %, P = 0.022; Table 4). Grip strength was maintained with 
ST and appeared to decline slightly in controls [56]. Lower body strength from a single 
study showed signs of improvement, but the change was not significant [56]. 
 
Body Composition: Body composition was unchanged with ST, both in terms of fat and 
lean mass. 
 
Functional Assessment: ST showed a trend to improve chair stand performance 
(25 %, P = 0.094), but other functional tasks were unchanged. 
 
Mixed Cancers. Four studies met the study inclusion criteria. 
 
Strength Assessment: In the studies that combined cancer types, most cases were breast 
cancer (53 %), followed prostate (10 %), lymphoma (6.7 %), and colorectal (4.9 %) with 
less common cancers making up the remaining 25 % (Table 5). Lower body strength 
increased with ST (24 %, P = 0.051), but there was only a trend for upper body 
improvements (21 %, P = 0.106) and was unchanged in controls. 
 
Table 5. Effects of ST on strength, body composition, physical function, and psychosocial 
parameters in mixed cancer survivors 
  Study no. Subject no. Baseline mean (SD) Post-ST mean (SD) Mean Change 95 % CI Pvalue 
Strength 
Lower body composite (kg) 
 Exercise 4 251 71.7 (20.8) 89.1 (27.7) 17.4 −0.1–34.9 0.051 
 Control 1a 33 73.9 (35.8) 76.2 (29.5)c 2.3 – – 
Upper body composite (kg) 
 Exercise 4 265 27.2 (6.8) 33.0 (7.8) 5.8 −2.3–13.9 0.106 
 Control 2 66 28.2 (7.7) 27.9 (6.1) −0.3 −14.9–14.4 0.864 
Body composition 
Absolute FM (kg) 
 Exercise 1a 20 28.5 (6.9) 28.8 (6.5)c 0.3 – – 
Absolute LM (kg) 
  Study no. Subject no. Baseline mean (SD) Post-ST mean (SD) Mean Change 95 % CI Pvalue 
 Exercise 2 30 55.0 (2.9) 55.3 (1.3) 0.3 −14.3–15 0.812 
BF (%) 
 Exercise 2 54 33.3 (1.1) 33.4 (0.3) 0.1 −6.8–7.1 0.500 
 Control 1a 33 31.7 (8.6) 38.1 (8.1)b 6.4 – – 
Hip BMD (g/cm2) 
 Exercise 1a 20 0.8 (0.1) 0.8 (0.1) 0.0 – – 
Functional assessments 
12-min walk (m) 
 Exercise 1a 34 1022 (186) 1144 (185)b 122 – – 
 Control 1a 33 1035 (200) 983 (193) −52 – – 
6-min walk (m) 
 Exercise 2 87 459.8 (21.5) 492.8 (15.9) 33.0 −17.9–84 0.077 
6-m walk (s) 
 Exercise 1a 20 4.6 (0.5) 4.3 (0.4)b −0.3 – – 
50-ft walk (s) 
 Exercise 1a 10 11.9 (1.9) 10.5 (1.8)b −1.4 – – 
400-m walk (s) 
 Exercise 1a 20 262.6 (43.6) 255.4 (43.4)b −7.2 – – 
Psychosocial 
Fatigue 
MFSI (short form) 
 Exercise 1a 20 9.5 (20.1) 5.4 (14.2) −4.1 – – 
FSI (1–10) 
 Exercise 1a 187 3.3 (1.8) 2.5 (1.5)b −0.8 – – 
Anxiety 
BSI-18 (1–5) 
 Exercise 1a 20 2.4 (3.8) 2.1 (2.8)c −0.3 – – 
QOL 
MOS-36 (0–100) 
 Exercise 1a 20 44.2 (9.4) 46.2 (7.8) 2.0 – – 
Depression 
BSI-18 (1–5) 
 Exercise 1a 20 3.2 (4.8) 2.9 (5.2)c −0.3 – – 
Data from references [39••, 57, 58, 59]. Lower body composite includes leg extension and leg 
press. Upper body composite includes chest and overhead presses and seated row 
MFSI Multi-Dimensional Fatigue Symptom Inventory, FSI Fatigue Symptom Inventory, BSI-
18 Brief Symptom Inventory-18, MOS-36 Item Medical Outcome Study 36-Item Short-Form 
Health Survey 
aAs reported in original research article for variables with only one study 
bSignificantly different from baseline value, per original article 
cNo within-group P value provided in original article or supplementary data 
 
Body Composition: Similar to other cancers (with the exception of reduced % fat 
observed in breast cancer survivors), ST did not alter body composition. Of note, controls 
from one study did report a large increase in %fat, from 31.7 to 38.1 % [57]. 
 
Functional Assessment: Functional tasks showed increases with ST in individual studies, 
whereas 6-min walk distance showed only a tendency to improve (7.2 %, P = 0.077). 
Single studies also showed improvements in 12-min walk [57], 6- and 400-m walk [39••], 
and 50-ft walk [58] performances. 
 
Psychosocial Assessment: Limited data for fatigue and QoL was available, with 
improved fatigue noted in one study [59] but not another [39••]. QoL and depression 
were unchanged with ST. 
 
Table 6. Effects of ST on strength and body composition in germ cell cancer survivors 
  Subject no. Baseline mean (SD) Post-ST mean (SD) Mean change 
Strength 
Leg press (kg) 
 Exercise 15 155 (38) 194 (41)a 39 
Body composition 
Absolute LM (kg) 
 Exercise 15 60.8 (8.2) 60.1 (8.1)a −0.7 
 Control 15 61.0 (5.4) 58.9 (4.2)a −2.1 
Quadriceps fiber area (um2) 
 Exercise 15 4877 (812) 5190 (1108) 313 
 Control 15 4576 (1028) 4272 (605) −304 
Data from reference [60] 
aSignificantly different than baseline value per original article 
 
Table 7. Effects of ST on strength and psychosocial parameters in gastro-intestinal cancer 
survivors 
  Subject no. Baseline mean (SD) Post-ST mean (SD) Mean change 
Strength 
 15RM knee flexor (kg) 11 13.7 (5.6) 16.0 (5.3)a 2.3 
 15RM knee extensor (kg) 11 14.5 (7.3) 15.0 (5.5) 0.5 
 15RM biceps (kg) 11 13.0 (4.7) 19.0 (6.8)a 6.0 
 15RM triceps (kg) 11 11.1 (4.0) 14.5 (5.3) 3.4 
 15RM back (kg) 11 11.1 (3.2) 15.7 (7.9)a 4.6 
Psychosocial 
 Fatigue 13 70.7 (21.2) 46.5 (24.3)a −24.2 
 QOL 17 42.4 (29.7) 56.9 (45.6) 14.5 
Data from reference [49] 
QOL: EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality 
of Life Questionnaire C30 
aSignificantly different than baseline value per original article 
 
Other Cancers. Four studies met the study inclusion criteria. 
 
For germ cell and gastro-intestinal cancers, only one study per cancer type examining the effects 
of ST was available [49, 60], while two studies were available for lung cancer [50, 51]. 
Additionally, control data was presented only for germ cell cancer [60]. 
 
Strength Assessment: ST appeared to be effective across all studies, with a 25 % 
improvement in leg press 1RM (Table 6) and 17–46 % in 15RM (Table 7) across the 
major muscle groups for germ cell and gastro-intestinal cancers, respectively. ST also 
increased upper (31 %, P = 0.182) and lower (31 %, P = 0.280) body strengths in lung 
cancer survivors, but these changes did not reach significance (Table 8). 
 
Body Composition: Lean mass and % fat were unaltered with ST in lung and germ cell 
cancers [49, 50]. There was, however, a 6.4 % increase in quadriceps fiber area with ST 
in germ cell cancer survivors, while controls showed a decrease of −6.6 % (Table 6), 
although these differences were not significant [60]. No body composition data was 
reported for gastro-intestinal patients. 
 
Table 8. Effects of ST on strength, physical function, and psychosocial parameters in lung 
cancer survivors 
  Study no. Subject no. Baseline -mean (SD) Post-ST mean (SD) Mean change CI Pvalue 
Strength 
 Lower body composite (kg) 3 159 53.1 (24.8) 69.7 (36) 16.6 −18.8–52.0 0.182 
 Upper body composite (kg) 2 88 32.8 (4.9) 42.8 (11.7) 10.0 −51.0–71.0 0.280 
Body composition 
 BF% 1a 15 34.1 (9.1) 34.1 (9.1) 0.0 – – 
 Absolute LM (kg) 1a 15 43.0 (9.7) 43.1 (9.2) 0.1 – – 
Functional assessments 
 6-min walk test (m) 2 86 489.0 (53.3) 549.5 (16.3) 60.5 −273.1–392.8 0.285 
 Up and go (s) 1a 15 6.3 (1.6) 5.5 (5.5)b −0.8 – – 
 Chair stand (reps in 30 s) 1a 15 11.2 (3.1) 15.4 (3.8)b 4.2 – – 
 Arm curl (reps in 30 s) 1a 15 14.6 (3.1) 18.2 (3.2)b 3.6 – – 
Aerobic capacity 
 VO2peak(mL/kg/min) 1a 71 1.3 (0.4) 1.4 (0.5)b 0.1 – – 
Psychosocial               
Anxiety 
 SSAS10 1a 15 15.1 (3.0) 14.5 (3.0) −0.6 – – 
 HADS-A 1a 71 7.2 (4.4) 6.3 (4.2)b −0.9 – – 
Depression 
 ESSD 1a 15 3.8 (4.2) 4.4 (5.6) 0.6 – – 
 HADS-A 1a 71 5.3 (3.8) 4.7 (3.5) −0.6 – – 
Fatigue 1a 15 45.6 (5.2) 46.1 (7.0) 0.5 – – 
QOL 
 SF36 1a 15 50.3 (7.9) 53.2 (8.1) 2.9 – – 
 FACT-L 1a 71 94.4 (18.9) 96.0 (18.4) 1.6 – – 
Data from references [50, 51] 
SSAS10 10-item Spielberger state anxiety scale, ESSD epidemiologic studies short 
depression, QOL quality of life, SF36 short-form health survey, HADS-A hospital anxiety and 
depression, FACT-L functional assessment of cancer therapy-lung 
aAs reported in original research article for variables with only one study 
bSignificantly different from baseline value per original article 
 
Functional Assessment: Physical function was assessed in lung cancer survivors, and 6-
min walk distance increased by 60 m but was not significantly different from baseline 
(P = 0.285). Improvements were seen in other tasks (13–38 %; Table 8) as reported in a 
single study [50]. 
 
Psychosocial Assessment: Collectively, the improvements in strength and function 
(where measured) did not appear to consistently translate into improved fatigue or QoL. 
In gastro-intestinal cancer survivors, fatigue scores worsened during the ST intervention 
but there was no change in QoL (Table 7) [49]. Fatigue, depression, anxiety, and QoL 
were all unchanged with ST in lung cancer patients (Table 8) [50]. 
 
Isokinetic and Isometric Maximal Strength Assessment 
 
A few studies examined the role of ST on isokinetic and isometric maximal strength. Because the 
number of studies overall was low (N = 6), the data were grouped together to provide a general 
overview of these studies results. ST increased isokinetic strength in seven out of eight tasks, 
while controls only increased in two tasks, as shown in Table 9 [30, 61]. Isometric strength 
showed similar findings, with eight tasks out of a possible nine being higher following ST 
[26, 30, 48], a single instance where it was unchanged but was decreased in controls [60], and a 
study which reported an increase in right leg but not left quadriceps strength [34]. 
 
Table 9. Isokinetic and isometric muscle strength changes following ST 
  Author, year Subject 
no. 
Cancer type Movement Baseline mean 
(SD) 
Post-ST mean 
(SD) 
Change (+, −, and 
n.s.) 
Isokinetic Twiss et al. 2009 110 Breast Hip extension at 60°/s 
(Nm/kg) 
27.7 35.6 +7.9 
113 Control 27.3 28.6 n.s. 
110 Breast Hip flexion at 60°/s 
(Nm/kg) 
30.5 33.4 +2.9 
113 Control 30.3 29.4 n.s. 
110 Breast Knee extension at 60°/s 
(Nm/kg) 
37.9 42.3 +4.4 
113 Control 36.7 36.9 n.s. 
110 Breast Knee flexion at 60°/s 
(Nm/kg) 
18.5 22.4 +3.9 
113 Control 18.4 18.4 n.s. 
110 Breast Wrist extension at 60°/s 
(Nm/kg) 
3.6 4.3 n.s. 
113 Control 3.4 4.1 +0.7 
110 Breast Wrist flexion at 60°/s 
(Nm/kg) 
3.8 7.5 +3.7 
113 Control 3.8 4.6 +0.8 
Lonbro et al. 2013 19 Head and 
neck 
Knee extension at 60°/s 
(Nm) 
141 156 +15 
19 Head and 
neck 
Knee flexion at 60°/s 
(Nm) 
80 97 +17 
  Schmidt et al. 2015 21 Breast Leg press (Nm) 85.6 (33.0) 90.1 (29.2) n.s. 
26 Control   79.7 (24.5) 80.0 (26.5) n.s. 
21 Breast Bench press (Nm) 113.0 (54.5) 148.5 (37.5) +35.5 
26 Control   85.3 (36.5) 91.3 (29.0) n.s. 
21 Breast Latissimus pull-down 
(Nm) 
111.5 (48.5) 147.0 (38.0) +35.5 
26 Control   94.2 (42.3) 96.5 (32.8) n.s. 
  Author, year Subject 
no. 
Cancer type Movement Baseline mean 
(SD) 
Post-ST mean 
(SD) 
Change (+, −, and 
n.s.) 
Isometric Lonbro et al. 2013 19 Head and 
neck 
Knee extension (Nm) 168 202 +33 
19 Head and 
neck 
Knee flexion (Nm) 95 111 +16 
Johansson et al. 
2014 
26 Breast Elbow extensors (N) 141 (25) 154 (27) +13 
26 Breast Elbow flexors (N) 214 (33) 227 (33) +13 
26 Breast Shoulder adductors (N) 138 (30) 155 (27) +17 
26 Breast Shoulder flexors (N) 185 (37) 199 (36) +14 
Christensen et al. 
2014 
15 Germ cell Quadricep (Nm) 247 (59) 249 (66) n.s. 
15 Control 223 (36) 195 (39) −28 
Hansen et al. 2009 5 Prostate 
(ADT) 
Left quadricep (Nm) 336.4 (47.7) 361.9 (84.4) n.s. 
5 Prostate 302.1 (61.9) 298.1 (35.6) n.s. 
5 Prostate 
(ADT) 
Right quadricep (Nm) 323.0 (94.9) 385.9 (125.8) +62.9 
5 Prostate 299.5 (55.5) 342.9 (50.8) n.s. 
Data from references [26, 30, 34, 48, 60, 61] 
n.s. non-significant change, + significant increase from baseline per original paper, and − 
significant decrease from baseline per original paper 
 
Discussion 
 
The primary focus of this review was to assess the independent effects of ST across different 
types of cancer survivors to determine its efficacy in reducing the side effects of treatment. 
Overall, 39 studies across seven different cancer types were identified as having completed 
isolated ST intervention with nearly 70 % of the data coming from studies conducted in breast 
(42 %) or prostate (26 %) cancers. Of the remaining cancer types, conclusions were drawn from 
only four studies (head and neck and mixed), two studies in lung, and a single study each in germ 
cell and gastro-intestinal cancers that ranged on the intensity, length, and frequency of ST and 
also the cancer stage of the participants. Overall, the independent effects of ST are still limited, 
with much that remains unclear, as studies have yet to directly compare many basic fitness 
principles within cancer populations. Instead, exercise interventions from healthy older adults 
have been the preliminary basis for studies in cancer survivors. However, the response in cancer 
patients may not always follow the same response as healthy individuals, perhaps due to 
systemic changes that occur during or following treatment or due to the disease itself; thus, there 
is a pressing need to examine ST in specific oncology populations. While the choice of ST 
interventions alone does limit the available pool of studies, it does give specific insight into what 
effects ST has, whereas previous approaches have permitted combined interventions (e.g., ST + 
aerobic and ST + impact training) and the relative contribution of each cannot be determined 
[19, 20, 53••]. Due to the relatively low number of studies in each cancer group that met the 
inclusion criteria for this systematic review of the literature, for the purpose of organization, this 
discussion will be separated by the different outcomes assessed. Lastly, recommendations for 
future research are provided. 
 
Strength 
 
Not surprisingly, studies routinely show robust improvements in maximal strength ranging from 
20 to 50 % of the initial value, indicating that the training programs were effective. Some of the 
control populations also showed improvements in strength (on occasion significant), which is 
suggestive of a learning effect that does lessen the overall magnitude of improvement, making 
the results difficult to interpret. Therefore, an adequate familiarization session, where survivors 
are introduced and experience different modes of strength testing prior to undergoing baseline 
testing, is an area that should be given much more attention for the improvement of the scientific 
rigor necessary for more objective interpretation of study results. This issue continues to plague 
the field of strength research, despite being raised as a limitation several years ago [19]. 
 
The possible learning effect observed in some of the control populations during strength testing 
suggests that the maximal strength values at baseline were likely to be less than true maximums. 
Because percentages of 1RM were used to prescribe intensity, reporting lower 1RM values has 
two effects: (1) overestimation of the actual training response and (2) potentially fails to provide 
the optimal stimulus for adaptation, particularly in studies using lower-intensity training ranges. 
However, despite the potentially reduced training stimulus, strength adaptations are still likely to 
occur in untrained populations. Because gains in strength do not transfer directly to higher 
functional capacity or QoL [35, 52], diminished improvements in strength can occur without the 
corresponding changes in other areas, likely due to the multi-factorial nature of functional tasks 
and QoL and sub-optimal training loads. 
 
Body Composition 
 
Body composition was rarely altered with ST except for the change in % fat in breast cancer, 
although in a few instances, body composition worsened in controls, suggesting that ST may be 
able to maintain current fat and lean mass levels, in general. Prostate cancer was the only other 
cancer with any indication of improvements, as trends were present for improved lean mass and 
consequently decreased % fat. Interestingly, the only potential changes in body composition 
were in hormone-dependent cancers, which made up the majority of studies and may have been 
the only types sufficiently powered to detect statistical differences. Another influential factor 
may have been the average length of the breast cancer interventions, which was on average at 
least eight weeks longer. The relatively small caloric deficits ensuing from each ST session 
would have had greater opportunity to influence body composition. As exercise intensity and 
frequency were similar across cancer types, they do not appear to play an obvious role. However, 
if the interventions were structured toward only two training sessions per week and used lower 
exercise intensity, these could also contribute to the lack of change due to reduced training 
volume. Finally, the impact of diet was not examined within this review, as exercise + dietary 
interventions were excluded. But, either caloric excesses or deficits would impact on fat and lean 
mass gains, respectively, and should be considered for future exploration within exercise 
oncology. 
 
Physical Function and Aerobic Capacity 
 
Despite the lower number of studies, particularly in the less common cancers, ST primarily 
promotes gains in physical function that would offer benefit to the cancer survivor. 
Improvements in functionality were most consistent in prostate, with all tasks having multiple 
studies contributing to the aggregate score and all but one task (chair stand time) was 
significantly improved from baseline. Other cancers, even breast, usually had a wide range of 
physical function assessments, so performing a formal analysis was not often possible. 
Alternatively, many tasks did improve but are from individual studies and only suggest possible 
effects of specific training protocols. It is curious as to why prostate functional outcomes were 
more consistent relative to others. Relatively few explanations are apparent, as the exercise 
training programs were similar to other cancers for duration, intensity, training frequency, 
disease stage, and strength improvements. While strength is associated with functional status at 
baseline [62], and alterations in strength may be indicative of changes in physical function, it 
only explains a relatively small component of the improvements [35, 52]. 
 
Despite studies showing that ST can improve aerobic capacity in older adults [63, 64], the 
changes in cancer survivors are minimal. This is not surprising, given that VO2peak was often a 
secondary outcome and studies were not likely powered to detect changes. Additionally, ST is 
not the optimal intervention to improve oxygen uptake, and without any change in body 
composition or total mass, relative aerobic capacity remains stable as well. Conversely, 6- and 
12-min walk tests and 400-m walk times significantly improved in several different cancer 
populations (prostate, mixed, and breast). These functional tasks are often used as inexpensive, 
quick, and safe clinical tests to estimate aerobic capacity and have been validated as a predictor 
of VO2peak in cancer patients [65]. The exact reasons for this discrepancy are not apparent but 
could be related to the validity of performing cardiopulmonary testing in cancer populations. 
 
Psychosocial Assessment 
 
Improved musculoskeletal function, body composition, and physical function all contribute to 
fatigue, QoL, and other psychological factors. Given that muscle and physical functions both 
improved, it is reasonable to expect that psychosocial parameters would follow suit. Previous 
work has shown that increased muscle endurance was linked to lower fatigue levels, and lower 
fatigue and greater physical function are associated with higher QoL in prostate cancer patients 
[35]. Surprisingly, despite consistent improvements elsewhere, psychosocial improvements were 
rare. Similar to physical function but to an even greater extent, the assessments used were highly 
variable. In fact, only breast and prostate had multiple studies that used the same questionnaire 
for at least one outcome. Of the ~30 psychosocial components examined, only body image and 
relationship improved with ST in breast cancer and fatigue in prostate improved with ST. No 
change in prostate QoL was found. Single studies do report improved psychosocial parameters 
but are subject to the limitations seen with physical function. Moreover, in several instances, 
within-group analysis was not performed or change scores only were reported, further reducing 
the number of possible outcomes to analyze. Finally, trials that include only a single arm or were 
pilot studies are susceptible to an attention bias rather than strictly the effects of the ST 
intervention. While even modest improvements in fatigue, QoL, or other variables is an 
important outcome, given that it is the patient’s perception that is being evaluated, the lack of 
consistency across this area makes definite conclusions regarding the effects of ST impossible at 
this time. 
 
 
 
Exercise Interventions 
 
There are some common themes across the different ST interventions in cancer survivors. 
Typically, studies focused on training the major muscle groups, which follows current 
recommendations to maximize benefits following ST in untrained individuals. Most participants 
trained two to three times per week, which corresponds to position stands on training frequency 
put forth by several governing bodies [66, 67] and is similar to recommendations in healthy older 
adults and other clinical populations [10, 54, 68]. Interestingly, exercise frequency in prostate 
cancer was recently investigated and found that more frequent training tended to show greater 
improvements in strength and functional tasks, whereas less frequent training improved 
psychosocial function to a greater extent [47••] and is, to our knowledge, one of the first studies 
to examine this within oncology patients. Exercise intensity ranged from 50 to 85 % of maximal 
strength, covering a spectrum from low to moderate intensity up to near maximal loads. While 
not consistently reported, the lack of adverse events indicates that higher-intensity ST appears 
safe, possibly even more effective. Strength gains in older adults showed a positive, linear 
relationship with intensity from 50 up to 90 % and were a strong factor in predicting 
improvement [54]. Current studies in cancer tend to show a similar pattern; however, while 
intensity may be in the optimal range, the volume of work being performed is often reduced. 
Thus, when these factors are combined to determine training load (sets × repetitions × 
resistance), the resulting training stimulus appears to be somewhat conservative; however, 
improvements in strength have been observed across the board. Given the paucity of data thus 
far, this cautious approach is reasonable but should be a focal point of future investigations, 
particularly in stable cancer survivors, where the effects of different volumes and intensity of 
training must be explored. Lastly, exercise adherence rates need to be reported. In recent years, 
this information has become more prevalent in the literature but some studies do not set 
attendance requirements. Conducting research with cancer survivors presents many challenges 
with respect to recruiting and retaining participants, so it is understandable why researchers may 
hesitate to do so. However, by recording voluntary rather than requiring specific adherence rates, 
this subtle difference may contribute significantly to the varying degree of adaptation observed 
with ST across studies. 
 
Recommendations for Future Research 
 
To move the field forward, there are several practical considerations to consider that may 
improve the overall depth of the field. First, exercise adherence needs to be reported and 
considered during analysis if participant participation rates vary. Second, familiarization of all 
primary outcomes (e.g., strength testing) needs to be standard practice and must be reported. This 
will better reflect the impact of ST and to allow for more accurate exercise prescription. The 
failure to familiarize likely skews the results of the intervention and makes interpretation of the 
true effects difficult. Next, the use of clinical exercise and functional tests (e.g., 6-min walk, 
timed up and go, and 1RM) would allow for a more standardized approach, and greater 
comparisons between ST protocols within and across cancer types would be possible. 
Additionally, many clinical tests have minimal clinically important difference [69] that assist 
physicians in judging the effectiveness of ST interventions and could be an important factor in 
demonstrating the efficacy of exercise in cancer survivors. Finally, sample sizes need to expand 
beyond the traditional pilot studies in most cases. While exceptions always exist, multi-site 
randomized control trials across multiple sites will help promote exercise oncology toward 
becoming an accepted and physician-recommended therapy. Until then, ST in cancer patients 
will continue to be an effective complementary therapy before, during, and after treatment but 
the impact will be limited. Exercise interventions utilizing ST have great potential to impact the 
lives of cancer survivors, by helping to increase both quality and duration of life, particularly if 
such programs can expand to include effective home and community-based protocols that can be 
delivered on a large scale. 
 
Conclusions 
 
In summary, ST does appear to promote different benefits that might be specific to different 
cancer types; however, due to the low number of studies currently available in the literature, the 
only outcome that consistently showed significant improvements was the measurement of 
strength. Nevertheless, improvements in strength are of tremendous importance, since in many 
other clinical populations, it is associated with improved overall functionality, decreased risk of 
falls, and greater ability to perform activities of daily living. Similar finds could also be achieved 
in cancer patients, as physical function showed signs of being improved with ST. Therefore, 
future studies should continue to explore the effects of ST with appropriately powered 
methodologies examining the ST effects on many important health and QoL outcomes. 
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